Overview

Update
Acquisitions
1 Acquisition
Total Equity Funding
$394M in 4 Rounds from 5 Investors
Headquarters:
Seattle, Washington
Description:
The leader in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors.
Founders:
, ,
Categories:
Therapeutics, Health Care, Biotechnology
Website:
http://adaptivebiotech.com
Social:

Company Details

Update

Adaptive Biotechnologies is the pioneer and leader in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors.

We bring the accuracy and sensitivity of our immunosequencing platform into laboratories around the world to drive groundbreaking research in cancer and other immune-mediated diseases. We are also committed to translating immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care.

Funding Rounds (5) - $396.5M

Update
DateAmount / RoundValuationLead InvestorInvestors
May, 2015$195M / Series F4
Jan, 2015$94M / Series E0
Apr, 2014$100M / Series D1
Apr, 2014$5M / Series C1
Sep, 2013$2.5M / Grant0

Acquisitions (1)

Update
DateAcquiredAmount
Jan 7, 2015Unknown

Current Team (11)

Update

Offices/Locations (2)

Update
  • Diagnostics

    329 Oyster Point Blvd., Ste 100

    South San Francisco, California 94080

    United States

  • Corporate Headquarters / Research

    1551 Eastlake Ave E

    Suite 200

    Seattle, Washington 98102

    United States

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos